Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kenneth Alan Bauer, M.D.

Co-Author

This page shows the publications co-authored by Kenneth Bauer and Jeffrey Zwicker.
Connection Strength

2.698
  1. How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. J Clin Oncol. 2014 Nov 10; 32(32):3596-9.
    View in: PubMed
    Score: 0.609
  2. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004 Dec; 2(12):2133-7.
    View in: PubMed
    Score: 0.308
  3. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020 09 10; 136(11):1342-1346.
    View in: PubMed
    Score: 0.230
  4. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. J Thromb Haemost. 2020 09; 18(9):2349-2357.
    View in: PubMed
    Score: 0.229
  5. Heparin induced thrombocytopenia antibodies in Covid-19. Am J Hematol. 2020 Jul 13.
    View in: PubMed
    Score: 0.227
  6. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. Blood Adv. 2020 05 26; 4(10):2254-2260.
    View in: PubMed
    Score: 0.225
  7. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight. 2019 02 21; 4(4).
    View in: PubMed
    Score: 0.206
  8. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol. 2013 Feb; 160(4):530-7.
    View in: PubMed
    Score: 0.134
  9. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012 Aug 07; 345:e4944.
    View in: PubMed
    Score: 0.131
  10. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J Thromb Haemost. 2010 Feb; 8(2):263-8.
    View in: PubMed
    Score: 0.109
  11. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009 Nov 15; 15(22):6830-40.
    View in: PubMed
    Score: 0.108
  12. Timing of postpartum enoxaparin administration and severe postpartum hemorrhage. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):55-9.
    View in: PubMed
    Score: 0.095
  13. The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood. 2006 Aug 15; 108(4):1280-3.
    View in: PubMed
    Score: 0.085
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.